AOA Dx Pioneers Translation of Lipid Biomarkers into a Targeted Multi-omic Assay, Achieving 92% Early-Stage Ovarian Cancer Sensitivity in Symptomatic Women
New results position lipidomics as a powerful new frontier in oncology diagnostics and advance AKRIVIS GD™ toward clinical launch